Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Case Report


Article page

323-325


Authors Details

Shone George*, Shiby Sara Shaji, Manish Mohan, M M Shahul Hameed, Jacob Jesurun


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 601

PDF Downloaded: 311


Case report on Ipratropium Bromide induced Anisocoria


Case Report

Author Details : Shone George*, Shiby Sara Shaji, Manish Mohan, M M Shahul Hameed, Jacob Jesurun

Volume : 10, Issue : 4, Year : 2023

Article Page : 323-325

https://doi.org/10.18231/j.ijpp.2023.054



Suggest article by email

Get Permission

Abstract

Anisocoria or unequal pupil size is an alarming sign of a neurologic emergency, especially when the patient is in a critical care setting. It is important to identify the aetiology of anisocoria and consider drug-induced anisocoria as a possible aetiology after ruling out underlying pathology if any. Ipratropium bromide, an anticholinergic drug, can cause anisocoria. This case report emphasises Ipratropium bromide-induced anisocoria.


Keywords: Anisocoria, Ipratropium bromide, Anticholinergic


How to cite : George S, Shaji S S, Mohan M, Hameed M M S, Jesurun J, Case report on Ipratropium Bromide induced Anisocoria. Indian J Pharm Pharmacol 2023;10(4):323-325

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.